MedTrace Logo

NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases

NCT06182956 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-12-27

No results posted yet for this study

Summary

The objectives of this study are to compare the physiological consequences of high-flow oxygen therapy and noninvasive mechanical ventilation on ventilation, respiratory work and hemodynamics during acute respiratory failure in diffuse interstitial pneumonia.

Conditions

Interventions

DEVICE

Noninvasive mechanical ventilation

Noninvasive mechanical ventilation is a respiratory technique which allows the administration of positive inspiratory and expiratory airway pressures in order to ventilate the lungs.

DEVICE

Nasal high-flow oxygen therapy

Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen.

DEVICE

Continuous positive airway pressure

Continuous positive airway pressure is a respiratory technique which allows to maintain a constant positive airway pressure during inspiration and expiration.

Sponsors & Collaborators

  • ADIR Association

    lead OTHER

Principal Investigators

  • Elise ARTAUD-MACARI, MD · University Hospital, Rouen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06182956 on ClinicalTrials.gov